Stock BPMC BLUEPRINT MEDICINES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Blueprint Medicines Corporation

Equities

BPMC

US09627Y1091

Real-time Estimate Cboe BZX
Other stock markets
 10:58:21 2024-06-04 am EDT 		5-day change 1st Jan Change
104 USD -0.81% Intraday chart for Blueprint Medicines Corporation +0.86% +11.93%
May. 23 Blueprint Medicines Says BLU-222 Combination Well Tolerated for Inhibitor in Type of Breast Cancer MT
May. 23 Blueprint Medicines Corporation to Present the First Promising and Most Advanced Clinical Data for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer at the 2024 ASCO Annual Meeting CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BPMC Stock
  4. News Blueprint Medicines Corporation
  5. MarketScreener Editorial Features